臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 总笔数 :2823024
	造访人次 : 30204847 在线人数 : 494 教育部委托研究计画计画执行:国立台湾大学图书馆

搜寻范围

进阶搜寻

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"vogelzang n j"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 11-20 / 20 (共1页)
1
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-02-02T00:46:53Z	Systemic therapy for metastatic urothelial carcinoma	Lin C.-C.; Hsu C.-H.; YEONG-SHIAU PU; Vogelzang N.J.
臺大學術典藏	2020-05-25T07:35:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Pu Y.-S.;Vogelzang N.J;Chen J;Cheng A.-L;Huang C.-Y;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Chen J; Vogelzang N.J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Pu Y.-S.;Vogelzang N.J;Chen J;Cheng A.-L;Huang C.-Y;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Chen J; Vogelzang N.J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:33Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Vogelzang N.J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:32Z	Systemic therapy for metastatic urothelial carcinoma	Chia-Chi Lin; Hsu C.-H; Pu Y.-S; Vogelzang N.J.
臺大學術典藏	2020-05-25T07:35:26Z	Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial	Smith D.C; Smith M.R; Sweeney C; Elfiky A.A; Logothetis C; Corn P.G; Vogelzang N.J; Small E.J; Harzstark A.L; Gordon M.S; Vaishampayan U.N; Haas N.B; Spira A.I; Lara Jr. P.N; Chia-Chi Lin; Srinivas S; Sella A; Sch?ffski P; Scheffold C; Weitzman A.L; Hussain M.
臺大學術典藏	2020-05-25T07:35:24Z	An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer	Stadler W.M; Vaughn D.J; Sonpavde G; Vogelzang N.J; Tagawa S.T; Petrylak D.P; Rosen P; Chia-Chi Lin; Mahoney J; Modi S; Lee P; Ernstoff M.S; Su W.-C; Spira A; Pilz K; Vinisko R; Schloss C; Fritsch H; Zhao C; Carducci M.A.
臺大學術典藏	2020-05-25T07:35:14Z	Optimal usage of radium-223 in metastatic castration-resistant prostate cancer	Cha T.-L; Wu T.T.-L; Vogelzang N.J; Huang C.-Y; Huang S.-P; Chia-Chi Lin; Ou Y.-C; Pang S.-T; Shen D.H.-Y; Wu W.-J; Chang W.Y.-H.
臺大學術典藏	2020-04-28T07:25:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2020-04-28T07:25:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.

显示项目 11-20 / 20 (共1页)
1
每页显示[10|25|50]项目